Q2 2024 Holdings
Filed 2024-08-14 | 35 holdings | $1.6B | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Apogee Therapeutics Inc(APGE) | COM | 03770N101 | $334.2M | 8,493,321 | 21.3% |
| Enliven Therapeutics Inc(ELVN) | COM | 29337E102 | $94.1M | 4,026,331 | 6.0% |
| 4D Molecular Therapeutics in(FDMT) | COM | 35104E100 | $92.4M | 4,400,000 | 5.9% |
| Ocular Therapeutix Inc(OCUL) | COM | 67576A100 | $87.3M | 12,762,462 | 5.6% |
| Dyne Therapeutics Inc(DYN) | COM | 26818M108 | $76.7M | 2,173,913 | 4.9% |
| Merus N V | COM | N5749R100 | $74.7M | 1,263,214 | 4.8% |
| Kalvista Pharmaceuticals Inc(KALV) | COM | 483497103 | $73.6M | 6,249,731 | 4.7% |
| Pharvaris N V(PHVS) | COM | N69605108 | $63.8M | 3,395,606 | 4.1% |
| Spyre Therapeutics Inc(SYRE) | COM NEW | 00773J202 | $63.1M | 2,685,448 | 4.0% |
| Dianthus Therapeutics Inc(DNTH) | COM | 252828108 | $54.2M | 2,094,373 | 3.5% |
| Viridian Therapeutics Inc(VRDN) | COM | 92790C104 | $50.5M | 3,882,671 | 3.2% |
| Cogent Biosciences Inc(COGT) | COM | 19240Q201 | $47.9M | 5,684,167 | 3.1% |
| Applied Therapeutics Inc(APLT) | COM | 03828A101 | $44.6M | 9,542,871 | 2.8% |
| Erasca Inc(ERAS) | COM | 29479A108 | $38.3M | 16,216,216 | 2.4% |
| Astria Therapeutics Inc(CATBUSD) | COM | 04635X102 | $32.8M | 3,608,645 | 2.1% |
| Edgewise Therapeutics Inc(EWTX) | COM | 28036F105 | $32.7M | 1,818,182 | 2.1% |
| Oric Pharmaceuticals Inc(ORIC) | COM | 68622P109 | $31.1M | 4,394,527 | 2.0% |
| Praxis Precision Medicines I(PRAX) | COM NEW | 74006W207 | $29.2M | 706,131 | 1.9% |
| Engene Holdings Inc(ENGN) | COM | 29286M105 | $26.6M | 2,825,983 | 1.7% |
| Cullinan Therapeutics Inc(CGEM) | COM | 230031106 | $24.1M | 1,379,965 | 1.5% |
| Terns Pharmaceuticals Inc(TERN) | COM | 880881107 | $23.2M | 3,410,058 | 1.5% |
| Mersana Therapeutics Inc | COM | 59045L106 | $22.8M | 11,328,000 | 1.4% |
| Zura BIO LTD(ZURA) | CLASS A ORD SHS | G9TY5A101 | $21.1M | 6,023,166 | 1.3% |
| Taysha Gene Therapies Inc(TSHA) | COM SHS | 877619106 | $20.2M | 9,000,000 | 1.3% |
| Abivax SA(ABVX) | SPONSORED ADS | 00370M103 | $17.8M | 1,345,780 | 1.1% |
| Arvinas Inc(ARVN) | COM | 04335A105 | $16.7M | 627,788 | 1.1% |
| Aquestive Therapeutics Inc(AQST) | COM | 03843E104 | $14.4M | 5,555,555 | 0.9% |
| Century Therapeutics Inc(IPSC) | COM | 15673T100 | $13.7M | 5,389,259 | 0.9% |
| Cabaletta BIO Inc(CABA) | COM | 12674W109 | $11.7M | 1,563,952 | 0.7% |
| Trevi Therapeutics Inc(TRVI) | COM | 89532M101 | $10.2M | 3,422,637 | 0.6% |
| Adverum Biotechnologies Inc(AVU0) | COM NEW | 00773U207 | $10.1M | 1,467,048 | 0.6% |
| Perceptive Cap Solutions COR | CL A ORD SHS | G70077105 | $7.5M | 750,000 | 0.5% |
| Tenaya Therapeutics Inc(TNYA) | COM | 87990A106 | $4.8M | 1,555,556 | 0.3% |
| Arca Biopharma Inc(ABIOEUR) | COM | 00211Y506 | $3.3M | 866,375 | 0.2% |
| Casi Pharmaceuticals Inc(CASIF) | ORD SHS | G1933S101 | $614.3K | 111,686 | 0.0% |